Medicines, 2024
Shortlist up to four to read them side by side.
657 medicine recalls FDA’s Enforcement Report published in 2024, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
657of 657 medicine recallsshown with your filters
The list
- Medicine recall Equate Cherry Cough Drops, Menthol cough suppressant/Oral Anesthetic, a) 30 drops per bag CGMP Deviations: Potential Glass and Silicone particulates in product Class IIFDA’s classFeb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Neptune’s Fix, Tianeptine Elixir, Fast Acting, 0.338 fl oz Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States. FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Neptune’s Fix, Tianeptine Extra Strength Elixir, 0.338 fl oz Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States. FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Neptune’s Fix, Tianeptine Tablets Extended Relief, Twenty Tablets per Box, Wide Awake, 3000 mg Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States. FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Norepinephrine Bitartrate Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary… Class IIFDA’s classFeb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted Labeling: Incorrect or Missing Package Insert Class IIFDA’s classFeb 28, 2024in FDA’s Enforcement Report3 statesnamed in where it went PublishedFeb 28, 2024ClassClass IIStatusTerminatedWhereIllinois, New Jersey and Ohio
- Medicine recall Pure Care Foaming Mint Hand Sanitizer 62% CGMP Deviations Class IIFDA’s classFeb 28, 2024in FDA’s Enforcement Report2 statesnamed in where it went PublishedFeb 28, 2024ClassClass IIStatusTerminatedWhereMichigan and North Carolina
- Medicine recall Fosfomycin Tromethamine Granules for Oral Solution, (equivalent to 3 grams of fosfomycin), single-dose sachet Failed Impurities/Degradation Specification: Out of specification for organic impurities Class IIFDA’s classFeb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Acthar Gel (repository corticotropin injection) 400 USP units/5mL cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Class IIFDA’s classFeb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Class IIFDA’s classFeb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Adrenalin (epinephrine) Injection 1mg/mL, 1mL single dose vial Labeling: Incorrect or Missing Lot and/or Exp Date. Class IIFDA’s classFeb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Sustain Herbal Dietary Supplement Marketed Without An Approved NDA/ANDA: FDA analysis found this product to be tainted with undeclared tadalafil, an ingredient found in FDA approved products… FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall SCHWINNNG Herbal Dietary Supplement Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product… FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Arize Herbal Dietary Supplement Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product… FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall TING 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Chemical Contamination; presence of benzene. FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IStatusCompletedWhereNationwide
- Medicine recall CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for Oral,… CGMP Deviations: Product was stored outside labeled storage temperature requirements. Class IIFDA’s classFeb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Clobazam Tablets 10mg, 100-count bottle CGMP Deviations: Out of specification for residual solvents. Class IIFDA’s classFeb 28, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35 Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets. Class IIIFDA’s classFeb 21, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 21, 2024ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen) Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets. Class IIIFDA’s classFeb 21, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 21, 2024ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall HydrALAZINE Hydrochloride Tablets, USP 10mg an out of specification result obtained during routine stability testing for Impurities. Class IIFDA’s classFeb 21, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 21, 2024ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Vasopressin 2 Units/2 mL Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date. Class IIFDA’s classFeb 21, 2024in FDA’s Enforcement ReportMinnesotathe one state its words name PublishedFeb 21, 2024ClassClass IIStatusOngoingWhereMinnesota
- Medicine recall Omeza Lidocaine Lavage pain relief oil 10*2mL VIALS CGMP Deviations Class IIFDA’s classFeb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Omeza Skin Protectant, Skin Protectant Gel 10*2mL Vials CGMP Deviations Class IIFDA’s classFeb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall CVS Health brand Lubricant Eye Drops (Carboxymethylcellulose Sodium 0.5%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Leader brand Lubricant Eye Drops (Carboxymethylcellulose Sodium 0.5%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall CVS Health brand Lubricant Eye Drops (Propylene glycol 0.6%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Rugby brand Polyvinyl Alcohol 1.4% Lubricating Eye Drops Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall CVS Health brand Lubricating Gel Drops (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Leader brand Dry Eye Relief (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall CVS brand Multi Action Relief Drops (Polyvinyl alcohol 0.5%, Povidone 0.6%, Tetrahydrozoline 0.05%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Leader brand Eye Irritation Relief (Polyvinyl alcohol 0.5%, Povidone 0.6%, Tetrahydrozoline 0.05%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall CVS Health brand, Lubricant Gel Drops (Carboxymethylcellulose Sodium 1%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Leader brand Dry Eye Relief (Carboxymethylcellulose Sodium 1%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Target brand High Performance Lubricant Eye Drops (Polyethylene glycol 400 0.4%, Propylene glycol 0.3%) a)… Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Leader brand Lubricant Eye Drops (Propylene glycol Eye Drops 0.6%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Velocity Pharma brand Lubricating Eye Drop (Propylene glycol Eye Drops 0.6%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall EQUATE brand Hydration PF Lubricant Eye Drops (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall LUBRICANT EYE DROPS (Carboxymethylcellulose Sodium 0.5%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall CVS Health brand Mild Moderate Lubricating Eye Drops (Propylene glycol 400 0.25%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Lubricant Gel Drops (Carboxymethylcellulose sodium 1.0%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Lubricant Gel Drops (Polyethylene glycol 400 0.4%, Propylene glycol 0.3%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Multi-action Relief Drops (Polyvinyl alcohol 0.5%, Providone 0.6%, Tetrahydrozoline Hydrochloride 0.05%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Lubricant Eye Drops (Propylene glycol 0.6%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Rugby brand Lubricating Tears Eye Drops (Dextran 70 0.1%, Hypromellose 2910 0.3%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Up&Up brand dry eye relief (Carboxymethylcellulose 0.5%) Non-Sterility FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Glimepiride Tablets, USP 1mg, 100-count bottles Misprint on tablet Class IIIFDA’s classFeb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall Glimepiride Tablets, USP 1mg, 500-count bottles Misprint on tablet Class IIIFDA’s classFeb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall Febuxostat Tablets, 40 mg, 30 Tablets CGMP Deviations Class IIFDA’s classFeb 14, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 14, 2024ClassClass IIStatusTerminatedWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.